Consensus Healthpeak Properties, Inc.

Equities

DOC

US42250P1030

Specialized REITs

Market Closed - Nyse Other stock markets 04:00:02 2025-12-05 pm EST			5-day change	1st Jan Change
17.02 ^USD	-0.93%		-6.79%	-16.03%

Nov. 24	Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $18, Maintains Equal Weight Rating	MT
Nov. 14	JPMorgan Adjusts Price Target on Healthpeak Properties to $18 From $20, Maintains Neutral Rating	MT

Evolution of the Average Target: Healthpeak Properties, Inc.

Evolution of the Target Price: Healthpeak Properties, Inc.

Changes in Analyst Recommendations: Healthpeak Properties, Inc.

88f68487d74de16d1dd5d9d0ca9344.naRPfo9MFCpHhSF7qOTlORGQAahEHyzPwMZ4qw91WSo.qvYVTucHJVAxz2QC-pOGVVDaZPscW0WstbIO3H4gNGXq0npO6SlbeRDOZA~574b2ef6101c65455e79fba717936a73

Analysts' recommendations: Healthpeak Properties, Inc.

Nov. 24	Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $18, Maintains Equal Weight Rating	MT
Nov. 14	JPMorgan Adjusts Price Target on Healthpeak Properties to $18 From $20, Maintains Neutral Rating	MT
Nov. 12	Baird Adjusts Price Target on Healthpeak Properties to $20 From $21, Maintains Outperform Rating	MT
Oct. 27	BNP Paribas Lowers Healthpeak Properties' Price Target to $22 From $24	MT
Oct. 01	Cantor Fitzgerald Initiates Healthpeak Properties at Neutral With $20 Price Target	MT
Sep. 15	Evercore ISI Adjusts Price Target on Healthpeak Properties to $22 From $23, Maintains Outperform Rating	MT
Sep. 15	Raymond James Upgrades Healthpeak Properties to Outperform From Market Perform, Price Target is $20	MT
Sep. 15	Analyst recommendations: Qiagen, Ionq, Mongodb, Oracle…
Aug. 28	JPMorgan Lowers Price Target on Healthpeak Properties to $20 From $22	MT
Aug. 28	Evercore ISI Adjusts Price Target on Healthpeak Properties to $23 From $22, Maintains Outperform Rating	MT
Aug. 27	Wells Fargo Adjusts Price Target on Healthpeak Properties to $18 From $20, Maintains Equalweight Rating	MT
Aug. 21	Morgan Stanley Adjusts Healthpeak Properties Price Target to $21 From $22, Maintains Overweight Rating	MT
Aug. 20	Deutsche Bank Downgrades Healthpeak Properties to Hold From Buy, Adjusts Price Target to $18 From $28	MT
Aug. 18	BMO Capital Adjusts Price Target on Healthpeak Properties to $20 From $21, Maintains Outperform Rating	MT
Aug. 06	Jefferies Adjusts Price Target on Healthpeak Properties to $21 From $20, Maintains Buy Rating	MT
Jul. 30	Baird Trims Healthpeak Properties Price Target to $21 From $22, Maintains Outperform Rating	MT
Jul. 29	Argus Research Adjusts Healthpeak Properties Price Target to $22 From $25	MT
Jul. 29	Scotiabank Downgrades Healthpeak Properties to Sector Perform From Sector Outperform, Adjusts PT to $19 From $21	MT
Jul. 28	BMO Capital Adjusts Price Target on Healthpeak Properties to $21 From $22, Maintains Outperform Rating	MT
Jul. 18	Evercore ISI Adjusts Healthpeak Properties Price Target to $22 From $21, Maintains Outperform Rating	MT
Jul. 11	Jefferies Trims Price Target on Healthpeak Properties to $20 From $21, Maintains Buy Rating	MT
Jun. 12	Mizuho Adjusts Price Target on Healthpeak Properties to $20 From $24	MT
Jun. 02	Citigroup Adjusts Price Target on Healthpeak Properties to $18 From $23	MT
May. 15	Jefferies Adjusts Price Target on Healthpeak Properties to $21 From $22, Maintains Buy Rating	MT
May. 14	JPMorgan Lowers Price Target on Healthpeak Properties to $22 From $24	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	HEALTHPEAK PROPERTIES, INC.					+22.89%
	WELLTOWER INC.					+2.18%
	VENTAS, INC.					+4.33%
	OMEGA HEALTHCARE INVESTORS, INC.					+0.73%
	AMERICAN HEALTHCARE REIT, INC.					+11.92%
	CARETRUST REIT, INC.					+6.58%
	HEALTHCARE REALTY TRUST INCORPORATED					+12.07%
	SABRA HEALTH CARE REIT, INC.					+7.72%
	CHARTWELL RETIREMENT RESIDENCES					+15.33%
	NATIONAL HEALTH INVESTORS, INC.					+9.68%
	Average					+9.34%
	Weighted average by Cap.					+4.70%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.02USD

Average target price

20.92USD

Spread / Average Target

+22.89%

High Price Target

29.00USD

Spread / Highest target

+70.39%

Low Price Target

18.00USD

Spread / Lowest Target

+5.76%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
JPMorgan Chase
Baird
BNP Paribas Exane
Cantor Fitzgerald
Evercore ISI
Raymond James
Morgan Stanley
Deutsche Bank Securities
BMO Capital
Jefferies & Co.
Argus
Scotiabank
Mizuho Securities
Citigroup
Wedbush
RBC Capital Markets
BofA Securities
Barclays
Wolfe Research
Berenberg Bank
Credit Suisse
J.P. Morgan Chase